Lipoic acid
- Generic Name
- Lipoic acid
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C8H14O2S2
- CAS Number
- 1200-22-2
- Unique Ingredient Identifier
- VLL71EBS9Z
- Background
A vitamin-like antioxidant.
- Indication
For nutritional supplementation, also for treating dietary shortage or imbalance.
- Associated Conditions
- Diabetic Neuropathies, Type 2 Diabetes Mellitus
- Associated Therapies
- Dietary and Nutritional Therapies, Nutritional supplementation
Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes
- First Posted Date
- 2013-11-07
- Last Posted Date
- 2013-11-08
- Lead Sponsor
- Xiang Guang-da
- Target Recruit Count
- 200
- Registration Number
- NCT01978405
- Locations
- 🇨🇳
Wuhan General Hospital, Wuhan, Hubei, China
Alpha-lipoic Acid Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease
- Conditions
- Interventions
- First Posted Date
- 2013-06-13
- Last Posted Date
- 2015-08-21
- Target Recruit Count
- 66
- Registration Number
- NCT01877590
- Locations
- 🇨🇳
Wuhan General Hospital, Wuhan, Hubei, China
Sympathetic Heart Innervation in Patients With Tako-Tsubo Cardiomyopathy
- Conditions
- Interventions
- First Posted Date
- 2012-02-02
- Last Posted Date
- 2016-01-27
- Lead Sponsor
- University of Campania "Luigi Vanvitelli"
- Target Recruit Count
- 90
- Registration Number
- NCT01524861
- Locations
- 🇮🇹
Dept Geriatric and Metabolic diseases SUN, Naples, Italy
A Clinical Trial for AMN: Validation of Biomarkers of Oxidative Stress, Efficacy and Safety of a Mixture of Antioxidants
- Conditions
- Interventions
- First Posted Date
- 2011-12-19
- Last Posted Date
- 2019-03-11
- Lead Sponsor
- Pujol, Aurora, M.D.
- Target Recruit Count
- 13
- Registration Number
- NCT01495260
- Locations
- 🇪🇸
Hospital Universitari de Bellvitge, L'Hospitalet de LLobregat, Barcelona, Spain
Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASH
- Conditions
- Interventions
- First Posted Date
- 2011-08-01
- Last Posted Date
- 2011-08-19
- Lead Sponsor
- Seoul St. Mary's Hospital
- Target Recruit Count
- 26
- Registration Number
- NCT01406704
Alpha-lipoic Acid in Patients at Risk for Paclitaxel Induced Neuropathy
- First Posted Date
- 2011-03-11
- Last Posted Date
- 2014-10-02
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 9
- Registration Number
- NCT01313117
- Locations
- 🇺🇸
Northwestern Medical Faculty Foundation, Chicago, Illinois, United States
Lipoic Acid as a Treatment for Acute Optic Neuritis
- First Posted Date
- 2011-02-11
- Last Posted Date
- 2019-04-26
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 31
- Registration Number
- NCT01294176
- Locations
- 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
Efficacy and Safety Study of Thioctacid Oral Tablets 600mg to Treat Chinese Diabetic Patients With Distal Symmetric Polyneuropathy
- First Posted Date
- 2010-10-20
- Last Posted Date
- 2010-10-21
- Lead Sponsor
- NovaMed Pharmaceuticals Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT01224353
- Locations
- 🇨🇳
The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
🇨🇳Wuxi No.2 People's Hospital, Wuxi, Jiangsu, China
🇨🇳Jiangsu Provincial People's Hospital, Nanjing, Jiangsu, China
Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)
- Conditions
- Interventions
- First Posted Date
- 2010-08-26
- Last Posted Date
- 2017-02-02
- Lead Sponsor
- VA Office of Research and Development
- Target Recruit Count
- 54
- Registration Number
- NCT01188811
- Locations
- 🇺🇸
VA Portland Health Care System, Portland, OR, Portland, Oregon, United States
The Effect of A-lipoic Acid (ALA) on Fatty Acid-induced Impairment of Glucose-stimulated Insulin Secretion
- First Posted Date
- 2010-01-26
- Last Posted Date
- 2012-10-02
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 15
- Registration Number
- NCT01056497
- Locations
- 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.